Good Morning & Happy Thursday! – 5/17/2018!
Check Out This Company’s Infographic!
This is A Marijuana Stocks Exclusive
See For Yourself
BREAKING NEWS: GT Biopharma Announces Update To OXS-3550 IND Filing, Its Most Advanced Tri-Specific Killer Engager
LOS ANGELES, CA, May 16, 2018 – GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris “GTBP.PA” or the “Company”), an immuno-oncology biotechnology company focused on innovative treatments based on the Company’s proprietary platforms, has reported that it expects to file the Investigational New Drug Application (“IND”) for OXS-3550, the Company’s most advanced Tri-specific Killer Engager (“TriKE”) product candidate, in mid-2018.
Read The Full Article Here
Gains in the U.S. Cannabis Index Vs. Canadian Index
The beginning of the year represented a slightly topsy-turvy period for the world of cannabis with a myriad of news hitting the industry in a very short period of time. Because of the new nature of the cannabis market, much of the industry still reacts as though it is in its infant stages. Since the beginning of the year, most of the stocks in the marijuana market have managed to bounce back, including several of the largest indexes in the market.
Read The Full Article Here
An affiliate of MAPH Enterprises LLC, MIDAM VENTURES LLC., a Florida Corporation has been compensated $2,000,000.00 by a GT Biopharma Inc. for a period beginning August 1, 2017 and ending ending May. 31, 2018 to publicly disseminate information about (GTBP). Midam owns zero shares.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
